002004 華邦健康
按盤價 
5.250 -0.160 (-2.957%)
5.250 -0.160 (-2.957%) | 2025/09 - 九個月 人民幣(K¥) | 與去年同期 比較 | 2024/12 人民幣(K¥) | 2023/12 人民幣(K¥) | 2022/12 人民幣(K¥) | 2021/12 人民幣(K¥) | ||
| 營業總收入 | 9,085,988 | 1.98% | 11,664,670 | 11,594,590 | 13,232,366 | 12,431,126 | |
| 減：營業總成本 | 8,097,647 | -0.21% | 10,758,061 | 10,449,044 | 11,557,133 | 11,386,506 | |
| 其中:營業成本 | 5,723,444 | 1.66% | 7,683,859 | 7,059,524 | 7,874,068 | 7,682,257 | |
| 財務費用 | 185,612 | -20.57% | 270,037 | 230,777 | 207,490 | 438,928 | |
| 資產減值損失 | (8,000) | -50.95% | (929,743) | (380,091) | (560,356) | (138,335) | |
| 公允價值變動收益 | 4,450 | 382.32% | 3,097 | 1,199 | (4,837) | 8,516 | |
| 投資收益 | 21,878 | -143.64% | (172,079) | 7,521 | 441,485 | 300,009 | |
| 其中：對聯營企業和合營企業的投資收益 | (6,147) | -92.01% | (215,163) | (28,839) | 425,722 | 239,099 | |
| 營業利潤 | 1,061,070 | 35.33% | (127,435) | 926,511 | 1,645,000 | 1,333,641 | |
| 利潤總額 | 1,087,340 | 41.50% | (160,507) | 892,388 | 1,622,696 | 1,281,246 | |
| 減：所得稅費用 | 207,906 | 13.41% | 182,086 | 215,456 | 495,488 | 361,042 | |
| 淨利潤 | 879,434 | 50.30% | (342,594) | 676,932 | 1,127,207 | 920,205 | |
| 減：非控股權益 | 267,614 | 101.00% | (43,604) | 374,810 | 693,724 | 252,395 | |
| 股東淨利潤 | 611,820 | 35.37% | (298,990) | 302,122 | 433,484 | 667,809 | |
市場價值指標 | |||||||
| 每股收益 (元) * | 0.310 | 35.53% | -0.151 | 0.153 | 0.219 | 0.337 | |
| 每股派息 (元) * | 0.200 | -- | -- | 0.220 | 0.220 | 0.220 | |
| 每股淨資產 (元) * | 4.899 | -4.06% | 4.716 | 5.104 | 5.148 | 5.106 | |
| 審計意見 # | -- | 标准的无保留意见 | 标准的无保留意见 | 标准的无保留意见 | 标准的无保留意见 | ||
| 備註： | *未調整數據 |
| #只提供簡體內容 | |
| 報價延遲最少15分鐘，資料更新時間為 19/03/2026 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
